ClinicalTrials.gg
RecruitingNCT05678556all2GETHERUpdated May 8, 2026

Effectiveness of Relationship Education for Reducing HIV Incidence Among Men Who Have Sex With Men

An interventional study of all2GETHER in Hiv, Chlamydia and Gonorrhea, sponsored by Northwestern University. Recruiting at 1 site in United States. Open to participants aged 16 Years to 34 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-08.

Primary conditionAcquired Immunodeficiency Syndrome(the registry's first term)UnverifiedIs this wrong?The registry often attaches Acquired Immunodeficiency Syndrome to studies about something else, and this study's title and listed conditions do not name it. No better condition is named, so the registry's term is kept.

Sponsored by Northwestern University · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Started Dec 2022; still recruiting 3 years 11 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
5,000
Allocation
Randomized
Ages
16 Years to 34 Years
Sex
All
01

Study summary

The purpose of this study is to upgrade an existing relationship education and HIV prevention program. This program is designed for gay, bisexual, queer, and transgender and non-binary people who partner with cisgender men. This means the program is designed for gay, bisexual and queer men, including both cisgender and transgender men. It is also designed for transgender and non-binary people who partner with cisgender men, including both transfeminine and transmasculine people. The investigators aim to test the effectiveness of this updated program among couples and single people.

Participants will complete online surveys and get tested for Chlamydia and Gonorrhea. Participants will be tested for urethral and rectal Chlamydia and Gonorrhea. Participants will also complete at-home point-of-care HIV testing, with confirmatory testing for preliminary positive results. They will also participate in our program on relationship education and HIV prevention. Study staff will follow up with participants for up to 2 years.

All participants will be randomized into one of two different conditions: the all2GETHER program or no program. "Randomized" means that it is completely up to chance which condition participants will be put into. Participants have a 50% chance of being assigned to either condition, similar to a coin toss. Participants should expect that they will be in this research study for 2 years. Participation in this study will be done remotely - participants will never need to come into a research lab.

Read the detailed description

The investigators will conduct a randomized controlled trial (RCT) with 5000 HIV-negative individuals, anticipating half of the individuals will have a serious partner, and half of those partnered individuals will enroll with their partner. After completing the baseline assessment, participants will be randomized to either the all2GETHER intervention package or follow-up only control, and they will be followed 24 months post-intervention. Only individuals participating with their partner will receive dyadic skills coaching sessions, while single and individual partnered MSM will receive the upgraded all2GETHER web app program only. all2GETHER web app delivers all core intervention content and uses diverse media (e.g., videos, interactive activities, quizzes) to deliver relationship education (e.g., effective communication, conflict resolution) and HIV prevention (e.g., behavioral/biomedical prevention, relationship agreements).

Eligibility Screening. Participants will be recruited via paid advertisement on traditional social media (e.g., Facebook, Instagram), geospatial dating apps (e.g., Grindr), and organic social media engagement (e.g., posts in Reddit threads). Online screening - online recruitment materials will be linked directly to the online eligibility screener. Potential participants will be greeted with a brief description of the project and will be asked if they are willing to answer some questions to assess their eligibility. Participants who meet initial eligibility criteria will be shown a message telling them that they are preliminarily eligible for the study and asked to provide their contact information. Those participants in a relationship will be asked to provide contact information for themselves and for their partner. If they do not consent to give contact information for their partner, the participant will be responsible for ensuring the partner also completes the screener. The investigators will make every effort to enroll the dyad - if partnered individuals cannot enroll their partner, they may participate as individuals.

Individual and Couple Confirmation. For couples - staff will confirm dyads as an actual couple, which involves separate calls to each partner with a series of questions about their relationship. Upon determining eligibility, and whether participation will be individual or dyadic, participants will be emailed a link to informed consent and baseline self-report questionnaire.

Baseline Assessment. Eligible participants will receive a link via email to access the online informed consent and baseline survey. Informed consent (assent for 16-17 year olds) will be completed just prior to completion of the baseline self-report questionnaire, via REDCap. Participants will be presented with the full online consent form. If they consent by clicking the 'I Agree' button at the bottom of the page, their consent will be recorded in our database. After obtaining consent/assent, participants will complete the baseline survey, which will take 45-50 minutes to complete. After completing the baseline survey, participants will be mailed HIV/STI testing kits. Participants will self-collect specimens using our team's established procedures, and return specimens for processing.

Randomization. After completing the baseline assessment, participants will be randomized to either the all2GETHER intervention package or follow-up only control, and they will be followed 24 months post-intervention. The all2GETHER intervention package will be tailored based on 2 decision rules: 1) Relationship status and (among partnered MSM) 2) individual v. dyadic participation. Only dyads will receive dyadic skills coaching sessions, while single and individual partnered MSM will receive the upgraded all2GETHER web app program only. Participating dyads will further receive 2 individualized couple sessions focused on skill implementation, emphasizing communication and problem-solving (Session 1) and sexual health (Session 2).

all2GETHER Intervention: The all2GETHER intervention package consists of 2 primary components: 1) all2GETHER web app (i.e., automated, interactive multimedia on relationship education and HIV prevention) and 2) dyadic skills coaching sessions. Mirroring pragmatic clinical decision-making, delivery of each component will be tailored to participant characteristics.

all2GETHER web app: Automated Relationship Education and HIV Prevention. Content will consist of 4 modules and contain: Confessional videos with real-life couples/singles, acted role plays, animated didactic videos, and interactive activities (e.g., problem-solving stress, goal setting for dating/relationships and HIV prevention).

Dyadic Skills Coaching Sessions: Participating dyads will receive all2GETHER web app + dyadic skills coaching sessions via videoconference using Zoom. Couples will complete 2 coaching sessions separated by 1 week that focus on implementation of skills, applied to the unique needs of each couple. Session 1 focuses on communication skills coaching, conflict resolution and problem-solving. Session 2 focuses on sexual satisfaction, preferences for monogamous/non-monogamous relationship agreements, and biomedical/behavioral HIV prevention.

Control Condition:

Participants in the control condition will receive no formal intervention, which is consistent with our primary aim of examining effectiveness on HIV incidence. The investigators will, however, provide all participants with HIV prevention resources from the CDC website and other national databases. The investigators will also assess exposure to other interventions that may be naturally occurring in participants' local context, which can be used to describe the sample and as a covariate (as necessary).

Facilitators. Facilitators will hold a bachelor's degree at minimum and have direct experience working with young adults and/or MSM. Facilitators will receive project- and university-specific training and will receive manualized training on HIV risk reduction and communication skills coaching. Weekly supervision groups will review and discuss issues that arise during sessions. Using BA-level facilitators means all2GETHER will be easier to implement in the community.

Post-Session Evaluations. After each individual or couple completes the all2GETHER web app they will complete a brief intervention and acceptability and tolerance survey. Additionally, dyads will be sent a brief list of questions post communication and sexual health session to gauge acceptability and session utility.

Assessment Timepoints. Follow-up assessments will occur at 6-, 12-, 18-, and 24-months postintervention. Follow-up at 6- and 18-months will include self-report questionnaire only; 12- months will additionally consist of self-collection of specimens for HIV/STI testing; and 24- months will also include STI/HIV testing. All assessments will last approximately 45-60 minutes will assess the same or analogous constructs.

Fidelity. Independent assessors review 20% of audio-recorded sessions and score them based on adherence to session protocol and ability to establish a collaborative relationship with participants.

02

Conditions studied

  • Hiv
  • Chlamydia
  • Gonorrhea

Browse trials for

03

In context

Acquired Immunodeficiency Syndrome Unverified

3,039 studies on the registry are indexed under Acquired Immunodeficiency Syndrome; 308 are open to participants now.

This study's planned enrollment of 5,000 is above the median of 96 across 2,254 interventional studies indexed under Acquired Immunodeficiency Syndrome.

Browse Acquired Immunodeficiency Syndrome studies →

Lead sponsor

Northwestern University is the lead sponsor of 1,424 studies on the registry; 199 are open to participants now.

Of its 105 completed or terminated interventional studies of FDA-regulated products, 78 (74%) have results posted.

Compared within Acquired Immunodeficiency Syndrome, the registry's first condition term, which may not be this study's main condition. Counted across the registry records on this site, refreshed daily. How we classify →

04

Who can participate

Ages eligible
16 Years to 34 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Cisgender men, transgender women and men, non-binary individuals
  • Had condomless anal sex with 2 or more serodiscordant/unknown-status cisgender male partners in the last 6 months
  • Aged 16-34 years
  • Lab-test confirmed -negative
  • Read and speak English at 8th grade level or better
  • Internet access
  • Agree to audio recording of intervention sessions
  • Provides address to receive HIV/STI test supplies
  • For dyads, both partners may enroll if they meet the above criteria- partners who are aged 35+ and/or HIV-positive may enroll in a more limited capacity

Exclusion criteria

Exclusion Criteria:

-Participants assigned female at birth who identify as women are not eligible

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

HIV

The human immunodeficiency virus, which weakens the immune system.

Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
5,000 participants (estimated)

Study arms

  • Experimental
    Experimental Arm

    all2GETHER is an HIV prevention and relationship education program designed for young MSM. all2GEHTER consists of 3 online didactic skills modules and 2 videoconference-based skills coaching sessions The 3 online modules focus on developmental skills related to sexual health and relationship functioning, including HIV prevention in couples, communication skills, coping skills, problem-solving and acceptance. Individualized couple sessions focus on implementation of skills specific to the needs of each couple.

    Behavioral: all2GETHER

  • No intervention
    Control Arm

    Participants will receive no intervention, but have access to HIV prevention resources from the CDC website and national databases. We will also assess exposure to other interventions that may be naturally occurring in participants' local context, which can be used to describe the sample and as a covariate (as necessary).

Interventions

  • Behavioralall2GETHER

    all2GETHER is an HIV prevention and relationship education program designed for young MSM and other individuals who have sex, date, and are in relationships with MSM. all2GEHTER consists of 3 online didactic skills modules that include videos, activities, and other self-paced education components and 2 videoconference-based skills coaching sessions The 3 online modules focus on developmental skills related to sexual health and relationship functioning, including HIV and STI prevention in couples, effective communication skills, coping skills for LGBTQ and relationship stress, problem-solving and acceptance. Individualized couple sessions led by facilitators focus on implementation of skills specific to the needs of each couple.

06

What researchers measure

Primary outcomes

  1. HIV infection

    Incidence of HIV confirmed via lab processed but self-administered collection

    Time frame: 24-months

Secondary outcomes

  1. Condomless Anal Sex

    Incidence of Condomless Anal Sex

    Time frame: 24-months

  2. Pre-Exposure Prophylaxis Use

    current use of HIV pre-exposure prophylaxis

    Time frame: 24-months

  3. Relationship Functioning

    among partnered participants, we will assess change in relationship satisfaction and dyadic communication

    Time frame: 24-months

  4. Sexually transmitted infections

    incidence of Chlamydia or Gonorrhea

    Time frame: 24-months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Sullivan PS, Salazar L, Buchbinder S, Sanchez TH. Estimating the proportion of HIV transmissions from main sex partners among men who have sex with men in five US cities. AIDS. 2009 Jun 1;23(9):1153-62. doi: 10.1097/QAD.0b013e32832baa34. PubMed 19417579 ↗
  • Greene GJ, Fisher KA, Kuper L, Andrews R, Mustanski B. "Is this normal? Is this not normal? There's no set example": Sexual Health Intervention Preferences of LGBT Youth in Romantic Relationships. Sex Res Social Policy. 2015 Mar;12(1):1-14. doi: 10.1007/s13178-014-0169-2. PubMed 25678895 ↗
  • Greene GJ, Andrews R, Kuper L, Mustanski B. Intimacy, monogamy, and condom problems drive unprotected sex among young men in serious relationships with other men: a mixed methods dyadic study. Arch Sex Behav. 2014 Jan;43(1):73-87. doi: 10.1007/s10508-013-0210-1. PubMed 24202113 ↗
  • Jiwatram-Negron T, El-Bassel N. Systematic review of couple-based HIV intervention and prevention studies: advantages, gaps, and future directions. AIDS Behav. 2014 Oct;18(10):1864-87. doi: 10.1007/s10461-014-0827-7. PubMed 24980246 ↗
  • Markman HJ, Rhoades GK. Relationship education research: current status and future directions. J Marital Fam Ther. 2012 Jan;38(1):169-200. doi: 10.1111/j.1752-0606.2011.00247.x. PubMed 22283386 ↗
  • Newcomb ME, Macapagal KR, Feinstein BA, Bettin E, Swann G, Whitton SW. Integrating HIV Prevention and Relationship Education for Young Same-Sex Male Couples: A Pilot Trial of the 2GETHER Intervention. AIDS Behav. 2017 Aug;21(8):2464-2478. doi: 10.1007/s10461-017-1674-0. PubMed 28083833 ↗
  • Newcomb ME, Sarno EL, Bettin E, Conway A, Carey J, Garcia C, Hill R, Jozsa K, Swann G, Addington EL, Ciolino JD, Macapagal K, Moskowitz JT, Mustanski B, Whitton SW. Protocol for an attention-matched randomized controlled trial of 2GETHER: a relationship education and HIV prevention program for young male couples. Trials. 2022 Jun 20;23(1):514. doi: 10.1186/s13063-022-06457-9. PubMed 35725624 ↗
  • Newcomb ME. Romantic relationships and sexual minority health: A review and description of the Dyadic Health Model. Clin Psychol Rev. 2020 Dec;82:101924. doi: 10.1016/j.cpr.2020.101924. Epub 2020 Sep 23. PubMed 33002795 ↗

Individual participant data

Plan to share: No — Any data shared with external researchers will be completely de-identified

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Dec 2022 (actual). Primary completion is estimated for Aug 2028, 68 months after the start.

Of 642 non-industry interventional studies with no phase under Acquired Immunodeficiency Syndrome, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 45. This study's planned 68 months is above that.

Counting every sponsor, half of 648 studies reached it within 29 months; a quarter within 17 and three quarters within 45.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 12, 2022
First posted
Jan 10, 2023
StartActual
Dec 15, 2022
Primary completionEst.
Aug 31, 2028
CompletionEst.
Aug 31, 2028
Last update
May 8, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 8, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05678556
Responsible party
Michael E. Newcomb (Associate Professor, Northwestern University) — Principal investigator
First posted
Jan 10, 2023
Start date
Dec 15, 2022
Primary completion
Aug 31, 2028 (estimated)
Completion
Aug 31, 2028 (estimated)
Last update
May 8, 2026

Study contacts

Michael E Newcomb, Ph.D.
Contact
newcomb@northwestern.edu
312-503-0702
Kathryn Macapagal, Ph.D.
Contact
kathryn.macapagal@northwestern.edu
312-503-3605
Michael E Newcomb, Ph.D
principal investigator · Northwestern University
Kathryn Macapagal, Ph.D
principal investigator · Northwestern University
Elissa Sarno, Ph.D
study director · Northwestern University
Brian Mustanski, Ph.D
principal investigator · Northwestern University
Dennis Li, Ph.D
principal investigator · Northwestern University
Jody Ciolino, Ph.D
principal investigator · Northwestern University
Jim Carey, MPH
study director · Northwestern University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion